vermillion inc (VRML:NASDAQ CM)

Executive Profile*

Background*

Mr. John F. Hamilton served as the Vice President of Finance and Chief Financial Officer of Depomed Inc. from January 1997 to October 12, 2007. Mr. Hamilton served as a Consultant at DepoMed Inc. from October 12, 2007 to October 2008. He served as a Vice President and Chief Financial Officer of Glyko, Inc. (now BioMarin Pharmaceuticals) and Glyko Biomedical Ltd., from May 1992 to September 1996. He served as the President of Treasurers Club of San Francisco. Mr. Hamilton ... has more than 20 years of experience in financial, strategic and audit matters. He served as the President and Chief Financial Officer of Protos Corporation, a drug design subsidiary of Chiron Corporation, from June 1988 to May 1992 and held various positions with Chiron Corporation, including Treasurer, from September 1987 to May 1992. Mr. Hamilton began his career in international banking with The Philadelphia National Bank and Crocker National Bank. He serves on the Regional Board of Directors of the Association of Bioscience Financial Officers. He served as a Director of Vermillion Inc from April 9, 2008 to March 21, 2013. He served as an Independent Director of Anesiva Inc. since February 12, 2009. Mr. Hamilton holds an M.B.A. from the University of Chicago and his B.A. in International Relations from the University of Pennsylvania.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
VRML:US	$2.59 USD	-0.04

COMPETITOR COMPENSATION